Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy BMO Capital Markets

Acadia Pharmaceuticals
Start price
€22.30
21.07.26 / 50%
Target price
€31.55
21.07.27
Performance (%)
9.46%
Price
€24.41
14.08.26
Summary
This prediction is currently active. With a performance of 9.46%, the BUY prediction by BMO_Capital_Markets for Acadia Pharmaceuticals is trending in the right direction. This prediction currently runs until 21.07.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w
Acadia Pharmaceuticals -3.441%
iShares Core DAX® 0,44 %
iShares Nasdaq 100 1,06 %
iShares Nikkei 225® 1,77 %
iShares S&P 500 0,37 %

Comments by BMO_Capital_Markets for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 9.46%
Target price 31.550
Change
Ends at 21.07.27

ACADIA Pharmaceuticals (ACAD) had its price target raised by BMO Capital Markets from $34.00 to $36.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat

BMO Capital Markets 
0
Report Share
21.07.26

Stopped prediction by BMO_Capital_Markets for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.41
19.05.25
€25.05
19.05.26
-9.74%
20.05.26

BMO Capital Markets 
19.05.25 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€15.27
27.06.24
€28.91
27.06.25
23.25%
28.06.25

BMO Capital Markets 
27.06.24 50%